Viewing Study NCT07280013


Ignite Creation Date: 2025-12-18 @ 9:48 AM
Ignite Modification Date: 2025-12-23 @ 6:58 PM
Study NCT ID: NCT07280013
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module